AMSF

AMERISAFE Inc
NASDAQFINANCIAL SERVICESINSURANCE - SPECIALTY

Key Statistics

Market Cap
$572.52M
P/E Ratio
12.10
EPS
$2.53
Beta
0.26
52W High
$44.61
52W Low
$29.04
50-Day MA
$32.20
200-Day MA
$35.60
Dividend Yield
5.32%
Profit Margin
14.00%
Forward P/E
22.37
PEG Ratio
1.81

About AMERISAFE Inc

AMERISAFE, Inc., an insurance holding company, writes workers' compensation insurance in the United States. The company is headquartered in DeRidder, Louisiana.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$335.66M
Gross Profit (TTM)$92.91M
EBITDA$59.29M
Operating Margin19.90%
Return on Equity18.20%
Return on Assets3.21%
Revenue/Share (TTM)$17.86
Book Value$13.50
Price-to-Book2.25
Price-to-Sales (TTM)1.71
EV/Revenue1.479
EV/EBITDA
Quarterly Earnings Growth (YoY)6.80%
Quarterly Revenue Growth (YoY)13.40%
Shares Outstanding$18.70M
Float$18.14M
% Insiders2.05%
% Institutions100.48%

Historical Volatility

HV 10-Day
53.34%
HV 20-Day
43.82%
HV 30-Day
41.69%
HV 60-Day
32.45%
HV Rank
99.6%

Volatility is currently expanding

Analyst Ratings

Consensus ($35.67 target)
1
Strong Buy
2
Hold

Latest News

AMERISAFE Q2 Earnings Call Highlights

AMERISAFE NASDAQ: AMSF reported higher second-quarter premiums and continued policy growth, while executives said the workers' compensation insurer is navigating a profitable but increasingly competitive market marked by rate pressure and rising medical costs.

MarketBeat7/22/2026Neutral
Can AMSF Sustain Growth Despite a Tough Workers' Compensation Market?

AMERISAFE, Inc. AMSF continues to distinguish itself in the workers' compensation insurance market through its focus on profitable growth, disciplined underwriting and conservative capital management. As pricing pressure persists across the industry, this strategy has helped the company maintain resilient operating performance and support its long-term investment outlook.

Zacks Investment Research7/13/2026Neutral
Amerisafe: Keeps Growing Into A Soft Market, But The Easy Comparisons Are Behind It

AMERISAFE delivered its eighth consecutive quarter of premium growth, with Q1 2026 net premiums up 9% to $75.1 million. Despite strong underwriting discipline and a 93.2% combined ratio, EPS declined year-over-year due to a normalization of the tax rate and rising loss ratios. Persistent industry rate softness and higher medical costs pressure AMSF's earnings outlook, warranting a Hold rating for patient investors.

Seeking Alpha4/29/2026Negative

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on AMSF and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More FINANCIAL SERVICES Stocks

Data last updated: 7/29/2026